Topical Gene Therapy B-VEC Offers New Hope for Butterfly Skin Disease
A new review confirms that beremagene geperpavec, the first FDA-approved topical gene therapy, significantly improves wound healing in dystrophic epidermolysis ...
A new review confirms that beremagene geperpavec, the first FDA-approved topical gene therapy, significantly improves wound healing in dystrophic epidermolysis ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine